Aurobindo Pharma has reported results for second quarter ended September 30, 2023 (Q2FY24).
The company has reported over 2-fold jump in its net profit at Rs 415.74 crore for the quarter under review as compared to Rs 164.63 crore for the same quarter in the previous year. Total income of the company increased by 36.54% at Rs 2,735.84 crore for Q2FY24 as compared to Rs 2,003.64 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 83.23% rise in its net profit at Rs 751.94 crore for Q2FY24 as compared to Rs 410.37 crore for the same quarter in the previous year. Total income of the company increased by 27.77% at Rs 7,406.40 crore for Q2FY24 as compared to Rs 5,796.56 crore for the corresponding quarter previous year.
